Patents by Inventor Daniel Jane-Wit

Daniel Jane-Wit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240024470
    Abstract: The disclosure provides a method of reducing the likelihood of forming a T cell-mediated allograft vasculopathy lesion in a mammalian transplant recipient comprising transplanting an allograft from a donor to a recipient and administering a therapeutically effective amount of an anti-C5 antibody, or antigen-binding fragment thereof, to the recipient, wherein the anti-C5 antibody, or antigen-binding fragment thereof reduces the likelihood of forming an allograft vasculopathy lesion in the allograft, compared to the absence of treatment with an anti-C5 antibody, or antigen-binding fragment thereof.
    Type: Application
    Filed: May 17, 2023
    Publication date: January 25, 2024
    Inventors: Jordan S. Pober, Daniel Jane-Wit, Lingfeng Qin, Yi Wang
  • Publication number: 20180311345
    Abstract: The disclosure provides a method of reducing the likelihood of forming a T cell-mediated allograft vasculopathy lesion in a mammalian transplant recipient comprising transplanting an allograft from a donor to a recipient and administering a therapeutically effective amount of an anti-C5 antibody, or antigen-binding fragment thereof, to the recipient, wherein the anti-C5 antibody, or antigen-binding fragment thereof reduces the likelihood of forming an allograft vasculopathy lesion in the allograft, compared to the absence of treatment with an anti-C5 antibody, or antigen-binding fragment thereof.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Applicants: Alexion Pharmaceuticals, Inc., Yale University
    Inventors: Jordan Pober, Daniel Jane-Wit, Lingfeng Qin, Yi Wang